TendieTensor TendieTensor
You’re browsing as
Guest
Free Preview
Sign in/sign up to unlock all features.

News  ›  GlobeNewswire Inc.

Zymeworks Announces Participation in Upcoming Investor Conferences

GlobeNewswire Inc. Logo GlobeNewswire Inc. By Zymeworks Inc.
Zymeworks Announces Participation in Upcoming Investor Conferences

Zymeworks, a clinical-stage biotechnology company, announced participation in upcoming investor conferences and highlighted its progress in developing biotherapeutics for cancer and other diseases, including the FDA-approved zanidatamab for biliary tract cancer.

Insights
ZYME   positive

Company has FDA-approved drug, ongoing clinical trials, strategic partnerships, and is presenting at investor conferences, indicating growth and potential